Dr. Liliana Antunes
Head of Product Testing, Co-founder
Liliana has extensive research experience in measuring DNA and RNA manipulation effects. At ExEd, she drives the experimental data generation for Engine validation and commercial partnerships.
Bio
Liliana completed her BSc and MSc degrees in Biochemistry at the University of Coimbra, Portugal, specialising in gene therapy and protein biochemistry. She obtained her PhD from the University of Cambridge, focusing on the interface of functional genomics and developmental biology under supervision of Prof Allan Bradley, Emmanouil Metzakopian and Pentao Liu. As a research associate in the Bradley Team, Liliana led a project to dissect druggable host-factors required for SARS-CoV-2 cell infection.
Prior to co-founding ExEd, Liliana worked alongside Kärt, testing every new iteration of ExEd’s foundational technology.
Liliana has extensive research experience in measuring DNA and RNA manipulation effects. At ExEd, she drives the experimental data generation for Engine validation and commercial partnerships.
Bio
Liliana completed her BSc and MSc degrees in Biochemistry at the University of Coimbra, Portugal, specialising in gene therapy and protein biochemistry. She obtained her PhD from the University of Cambridge, focusing on the interface of functional genomics and developmental biology under supervision of Prof Allan Bradley, Emmanouil Metzakopian and Pentao Liu. As a research associate in the Bradley Team, Liliana led a project to dissect druggable host-factors required for SARS-CoV-2 cell infection.
Prior to co-founding ExEd, Liliana worked alongside Kärt, testing every new iteration of ExEd’s foundational technology.
Liliana has extensive research experience in measuring DNA and RNA manipulation effects. At ExEd, she drives the experimental data generation for Engine validation and commercial partnerships.
Bio
Liliana completed her BSc and MSc degrees in Biochemistry at the University of Coimbra, Portugal, specialising in gene therapy and protein biochemistry. She obtained her PhD from the University of Cambridge, focusing on the interface of functional genomics and developmental biology under supervision of Prof Allan Bradley, Emmanouil Metzakopian and Pentao Liu. As a research associate in the Bradley Team, Liliana led a project to dissect druggable host-factors required for SARS-CoV-2 cell infection.
Prior to co-founding ExEd, Liliana worked alongside Kärt, testing every new iteration of ExEd’s foundational technology.
→